Metacrine's total assets for Q were $55.04M, a decrease of -6.94% from the previous quarter. MTCR total liabilities were $17.97M for the fiscal quarter, a 1.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.